GSC The List

Post Reply
Forum Home > B > BRAIN TRAUMA*

[email protected]
Site Owner
Posts: 1174

Exogenous anandamide protects rat brain against acute neuronal injury in vivo. (full – 2001) http://www.jneurosci.org/content/21/22/8765.long

Brain Injury Circumvented by Endocannabinoids (abst – 2001) http://stke.sciencemag.org/cgi/content/abstract/sigtrans;2001/104/tw380?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1680&resourcetype=HWCIT

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. (abst – 2001) http://www.ncbi.nlm.nih.gov/pubmed/11586361

Cannabinoids on the Brain (full – 2002) http://www.ukcia.org/research/CannabinoidsOnTheBrain.pdf

Cannabinoids and brain injury: therapeutic implications (full – 2002) http://www.ukcia.org/research/CannabinoidsAndBrainInjury.pdf

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/11990913?dopt=Abstract

Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14519516

BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14647528

Cannabinoids As Neuroprotective Agents in Traumatic Brain Injury. (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15281893

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration (full – 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435344/?tool=pmcentrez

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16364651

The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis (full – 2007) http://www.jbc.org/content/282/33/23892.full

Endocannabinoids and traumatic brain injury. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17952651

The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news – 2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en

The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. (full – 2008) http://www.fasebj.org/cgi/content/full/22/1/285

LSUHSC research reports new method to protect brain cells from diseases like Alzheimer’s (news – 2008) http://www.eurekalert.org/pub_releases/2008-08/lsuh-lrr082008.php

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750822/?tool=pmcentrez

Breakthrough in treatment of Traumatic Brain Injury: KeyNeurotek’s clinical study reaches primary endpoint and shows significant increase in survival (news – 2009) http://www.drugs.com/clinical_trials/breakthrough-traumatic-brain-injury-keyneurotek-s-clinical-studyreaches-primary-endpoint-shows-8667.html

September 11, 2014 at 5:32 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.